Combined LIM kinase 1 and p21-Activated kinase 4 inhibitor treatment exhibits potent preclinical antitumor efficacy in breast cancer - Concepedia

Concepedia

Publication | Closed Access

Combined LIM kinase 1 and p21-Activated kinase 4 inhibitor treatment exhibits potent preclinical antitumor efficacy in breast cancer

17

Citations

45

References

2020

Year

Chenchen Zhao, Mengna Zhan, Wan‐Ting Liu, Yang Jiao, Yiyin Zhang, Lei Yu, Teng-teng Zhang, Congjun Zhang, Yingying Du, Kangsheng Gu,

Breast OncologyP21-activated Kinase 4MedicinePharmacologyInhibitor TreatmentImmune Checkpoint InhibitorBreast CancerTumor SuppressorCancer TreatmentOncologyCell BiologyTumor Microenvironment

References

	Year	Citations

Page 1

Page 1